Voice Disorders
37
4
5
23
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.4%
2 terminated out of 37 trials
92.0%
+5.5% vs benchmark
3%
1 trials in Phase 3/4
22%
5 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (37)
Straw Phonation Exercise Program for Pitch Extension
DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia
Immersive Virtual Reality Meditation in Voice Therapy
Brain and Voice Signatures in Teachers
Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)
Project 4: Ambulatory Biofeedback and Voice Therapy for Patients With Vocal Hyperfunction
Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention
Voice Therapy With a Semi-occluded Vocal Tract
Improving Efficacy of Voice Therapy Concepts Via Telepractice and Mobile App Technology
RCT Face-to-face Group Voice Therapy vs Telepractice Group Voice Therapy for Muscle Tension Dysphonia
Investigating Muscle Training's Respiratory Outcomes and Voice Enhancement in Parkinson's Disease
Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID
Assessment of Laryngopharyngeal Sensation in Adductor Spasmodic Dysphonia
Correlation Between Montreal Cognitive Assessment and Voice Therapy Outcomes in the Aging Treatment- Seeking Population
The Effect of Combined Speech and Music-therapy on the Speech Characteristics of People With Parkinson's Disease (PD)
Voice Analysis in Patients With Neurologic Diseases
A Study to Evaluate Effects of Gargle Phonation in Voice
Neuropathology of Spasmodic Dysphonia
Personal Protective Equipment Effects
Multimodal Analysis of Structural Voice Disorders Based on Speech and Stroboscopic Laryngoscope Video